Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Interim laboratory biosafety guidelines for handling and processing specimens associated with 2019 novel coronavirus (2019-nCoV)
Filetype[PDF-59.22 KB]


Details:
You May Also Like:
  1. Frequently asked questions about laboratory biosafety and SARS-CoV-2
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    March 20, 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Specimen Handling -- Specimen Packing and Shipping.
    File Type:
    Filetype[PDF - 130.16 KB]
  2. Interim laboratory biosafety guidelines for handling and processing specimens associated with 2019 novel coronavirus (2019-nCoV)
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    February 2, 2020
    Series:
    2019 novel coronavirus, Wuhan, China
    Description:
    To date, we do not fully understand the pathogenic potential and transmission dynamics of 2019 Novel Coronavirus (2019-nCoV). Until more information becomes available, precautions should be taken in collecting and handling specimens that may contain ...
    File Type:
    Filetype[PDF - 59.23 KB]
  3. Interim laboratory biosafety guidelines for handling and processing specimens associated with 2019 novel coronavirus (2019-nCoV)
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    February 10, 2020
    Series:
    2019 novel coronavirus, Wuhan, China
    Description:
    On February 11, 2020 the World Health Organization announced an official name for the disease that is causing the 2019 novel coronavirus outbreak, COVID-19. CDC will be updating our website and other CDC materials to reflect the updated name.Revision...
    File Type:
    Filetype[PDF - 64.62 KB]
  4. Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    March 31, 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    March 31, 2020Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2. Timely communication between clinical and laboratory staff is essential to minimize the risk inc...
    File Type:
    Filetype[PDF - 114.55 KB]
  5. Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    January 17, 2020
    Series:
    2019 novel coronavirus, Wuhan, China
    Description:
    Health care providers should contact their local/state health department immediately to notify them of patients with fever and lower respiratory illness who traveled to Wuhan, China within 14 days of symptom onset. Local and state public health staff...
    File Type:
    Filetype[PDF - 56.95 KB]